Lingga, Mary Ann .
HRN: 26-32-38 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/04/2025
CEFAZOLIN 1GM (VIAL)
02/04/2025
02/05/2025
IV
2 Grams
Every 8 Hours
S/P Repeat CS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes